Document is current
Any future updates will be listed below
-
Authors
Ito, Fumiaki https://orcid.org/0000-0002-2274-118X
Li, Ziyuan
Minakhin, Leonid
Khant, Htet A.
Pomerantz, Richard T. https://orcid.org/0000-0003-1194-9871
Chen, Xiaojiang S. https://orcid.org/0000-0001-9574-0551
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI150524)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM152198)
- License Information
-
More Information
Article History
Received: 24 January 2025
Accepted: 24 March 2025
First Online: 19 April 2025
Competing interests
: X.S.C. is a cofounder of Recombination Therapeutics, LLC. R.T.P. is a cofounder and CSO of Recombination Therapeutics, LLC. The remaining authors declare no competing interests.
